-
1
-
-
0042671277
-
The human insulin analogue aspart is not the almighty solution for insulin allergy
-
10.2337/diacare.26.1.253-a, 12502700
-
Takata H, Kumon Y, Osaki F, Kumagai C, Arii K, Ikeda Y, Suehiro T, Hashimoto K. The human insulin analogue aspart is not the almighty solution for insulin allergy. Diabetes Care 2003, 26:253-254. 10.2337/diacare.26.1.253-a, 12502700.
-
(2003)
Diabetes Care
, vol.26
, pp. 253-254
-
-
Takata, H.1
Kumon, Y.2
Osaki, F.3
Kumagai, C.4
Arii, K.5
Ikeda, Y.6
Suehiro, T.7
Hashimoto, K.8
-
2
-
-
73549122165
-
Osteopontin is expressed and functional in human eosinophils
-
10.1111/j.1398-9995.2009.02148.x, 19804447
-
Puxeddu I, Berkman N, Ribatti D, Bader R, Haichi HM, Davies DE, Howarth PH, Levi-Schaffer F. Osteopontin is expressed and functional in human eosinophils. Allergy 2010, 65:168-174. 10.1111/j.1398-9995.2009.02148.x, 19804447.
-
(2010)
Allergy
, vol.65
, pp. 168-174
-
-
Puxeddu, I.1
Berkman, N.2
Ribatti, D.3
Bader, R.4
Haichi, H.M.5
Davies, D.E.6
Howarth, P.H.7
Levi-Schaffer, F.8
-
3
-
-
33645971027
-
High expression of eosinophil chemoattratant ecalectin/galectin-9 in drug induced liver injury
-
10.1111/j.1478-3231.2005.01189.x, 16420516
-
Takahashi Y, Fukusato T, Kobayashi Y, Akiyama S, Tamatani T, Shiga J, Mori S. High expression of eosinophil chemoattratant ecalectin/galectin-9 in drug induced liver injury. Liver Int 2006, 26:106-115. 10.1111/j.1478-3231.2005.01189.x, 16420516.
-
(2006)
Liver Int
, vol.26
, pp. 106-115
-
-
Takahashi, Y.1
Fukusato, T.2
Kobayashi, Y.3
Akiyama, S.4
Tamatani, T.5
Shiga, J.6
Mori, S.7
-
4
-
-
70349778176
-
Persistent elevation of plasma osteopontin levels in HIV patients despite highly active antiretroviral therapy
-
10.1620/tjem.218.285, 19638732
-
Chagan-Yasutan H, Saitoh H, Ashino Y, Arikawa T, Hirashima M, Li S, Usuzawa M, Oguma S, Telan EFO, Obi CL, Hattori T. Persistent elevation of plasma osteopontin levels in HIV patients despite highly active antiretroviral therapy. Tohoku J Exp Med 2009, 218:285-292. 10.1620/tjem.218.285, 19638732.
-
(2009)
Tohoku J Exp Med
, vol.218
, pp. 285-292
-
-
Chagan-Yasutan, H.1
Saitoh, H.2
Ashino, Y.3
Arikawa, T.4
Hirashima, M.5
Li, S.6
Usuzawa, M.7
Oguma, S.8
Telan, E.F.O.9
Obi, C.L.10
Hattori, T.11
-
5
-
-
70349245383
-
Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice
-
10.1002/eji.200839177, 19670381
-
Chou FC, Shieh SJ, Sytwu HK. Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice. Eur J Immunol 2009, 39:2403-2411. 10.1002/eji.200839177, 19670381.
-
(2009)
Eur J Immunol
, vol.39
, pp. 2403-2411
-
-
Chou, F.C.1
Shieh, S.J.2
Sytwu, H.K.3
-
6
-
-
0037208859
-
Serum soluble interleukin-2 receptor in eosinophilia
-
10.1159/000067274, 12486319
-
Kaito K, Otsubo H, Ogasawara Y, Kimura H, Kurihara E, Koike M, Aiso M, Kobayashi M. Serum soluble interleukin-2 receptor in eosinophilia. Acta Haematol 2003, 109:23-28. 10.1159/000067274, 12486319.
-
(2003)
Acta Haematol
, vol.109
, pp. 23-28
-
-
Kaito, K.1
Otsubo, H.2
Ogasawara, Y.3
Kimura, H.4
Kurihara, E.5
Koike, M.6
Aiso, M.7
Kobayashi, M.8
-
7
-
-
33750799063
-
Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis
-
10.1016/j.cgh.2006.08.013, 17059896
-
Konikoff MR, Blanchard C, Kirby C, Buckmeier BK, Cohen MB, Heubi JE, Putnam PE, Rothenberg ME. Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis. Clin Gastroenterol Hepatol 2006, 4:1328-1336. 10.1016/j.cgh.2006.08.013, 17059896.
-
(2006)
Clin Gastroenterol Hepatol
, vol.4
, pp. 1328-1336
-
-
Konikoff, M.R.1
Blanchard, C.2
Kirby, C.3
Buckmeier, B.K.4
Cohen, M.B.5
Heubi, J.E.6
Putnam, P.E.7
Rothenberg, M.E.8
-
8
-
-
0033256423
-
The basal plasma histamine level and eosinophil count in allergic and non-allergic patients [abstract]
-
Kimura K, Adachi M, Kubo K, Ikemoto Y. The basal plasma histamine level and eosinophil count in allergic and non-allergic patients [abstract]. Fukuoka Igaku Zasshi 1999, 90(12):457-463.
-
(1999)
Fukuoka Igaku Zasshi
, vol.90
, Issue.12
, pp. 457-463
-
-
Kimura, K.1
Adachi, M.2
Kubo, K.3
Ikemoto, Y.4
-
9
-
-
42249097456
-
Osteopontin is produced by mast cells and affects IgE-mediated degranulation and migration of mast cells
-
10.1002/eji.200737057, 18200503
-
Nagasaka A, Matsue H, Matsushima H, Aoki R, Nakamura Y, Kambe N, Kon S, Uede T, Shimada S. Osteopontin is produced by mast cells and affects IgE-mediated degranulation and migration of mast cells. Eur J Immunol 2008, 38:489-499. 10.1002/eji.200737057, 18200503.
-
(2008)
Eur J Immunol
, vol.38
, pp. 489-499
-
-
Nagasaka, A.1
Matsue, H.2
Matsushima, H.3
Aoki, R.4
Nakamura, Y.5
Kambe, N.6
Kon, S.7
Uede, T.8
Shimada, S.9
-
10
-
-
0026355716
-
The soluble interleukin-2 receptor as a marker for human neoplasia and immune status
-
Zerler B. The soluble interleukin-2 receptor as a marker for human neoplasia and immune status. Cancer Cells 1991, 3:471-479.
-
(1991)
Cancer Cells
, vol.3
, pp. 471-479
-
-
Zerler, B.1
-
11
-
-
33947224207
-
TIM-3 is expressed in melanoma cells and is upregulated in TGF-beta stimulated mast cells
-
10.1038/sj.jid.5700616, 17096021
-
Wiener Z, Kohalmi B, Pocza P, Jeager J, Tolgyesi G, Toth S, Gorbe E, Papp Z, Falus A. TIM-3 is expressed in melanoma cells and is upregulated in TGF-beta stimulated mast cells. J Invest Dermatol 2007, 127:906-914. 10.1038/sj.jid.5700616, 17096021.
-
(2007)
J Invest Dermatol
, vol.127
, pp. 906-914
-
-
Wiener, Z.1
Kohalmi, B.2
Pocza, P.3
Jeager, J.4
Tolgyesi, G.5
Toth, S.6
Gorbe, E.7
Papp, Z.8
Falus, A.9
-
12
-
-
77952298179
-
Involvement of galectin-9 in lung eosinophilia in patients with eosinophilic pneumonia
-
10.1159/000314371, 20484929
-
Katoh S, Nobumoto A, Matsumoto N, Matsumoto K, Ehara N, Niki T, Inada H, Nishi N, Yamauchi A, Fukushima K, Hirashima M. Involvement of galectin-9 in lung eosinophilia in patients with eosinophilic pneumonia. Int Arch Allergy Immunol 2010, 153:294-302. 10.1159/000314371, 20484929.
-
(2010)
Int Arch Allergy Immunol
, vol.153
, pp. 294-302
-
-
Katoh, S.1
Nobumoto, A.2
Matsumoto, N.3
Matsumoto, K.4
Ehara, N.5
Niki, T.6
Inada, H.7
Nishi, N.8
Yamauchi, A.9
Fukushima, K.10
Hirashima, M.11
-
13
-
-
70450265476
-
Galectin-9 is a high affinity IgE-binding lectin with anti-allergic effect by blocking IgE-antigen complex formation
-
10.1074/jbc.M109.035196, 19776007
-
Niki T, Tsutsui S, Hirose S, Aradono S, Sugimoto Y, Takeshita K, Nishi N, hirashima M. Galectin-9 is a high affinity IgE-binding lectin with anti-allergic effect by blocking IgE-antigen complex formation. J Biol Chem 2009, 284:32344-32352. 10.1074/jbc.M109.035196, 19776007.
-
(2009)
J Biol Chem
, vol.284
, pp. 32344-32352
-
-
Niki, T.1
Tsutsui, S.2
Hirose, S.3
Aradono, S.4
Sugimoto, Y.5
Takeshita, K.6
Nishi, N.7
hirashima, M.8
-
14
-
-
38849191822
-
Galectin-3 functions as an adhesion molecule to support eosinophil rolling and adhesion under conditions of flow
-
Rao SP, Wang Z, Zuberi RI, Sikora L, Bahaie NS, Zuraw BL, Liu FT, Sriramarao P. Galectin-3 functions as an adhesion molecule to support eosinophil rolling and adhesion under conditions of flow. J Immunol 2007, 179:7800-7807.
-
(2007)
J Immunol
, vol.179
, pp. 7800-7807
-
-
Rao, S.P.1
Wang, Z.2
Zuberi, R.I.3
Sikora, L.4
Bahaie, N.S.5
Zuraw, B.L.6
Liu, F.T.7
Sriramarao, P.8
-
15
-
-
7144226602
-
Galectin-3 down-regulates IL-5 gene expression on different cell types
-
Cortegano I, del Pozo V, Cárdaba B, de Andrés B, Gallardo S, del Amo A, Arrieta I, Jurado A, Palomino P, Liu FT, Lahoz C. Galectin-3 down-regulates IL-5 gene expression on different cell types. J Immunol 1998, 161:385-389.
-
(1998)
J Immunol
, vol.161
, pp. 385-389
-
-
Cortegano, I.1
del Pozo, V.2
Cárdaba, B.3
de Andrés, B.4
Gallardo, S.5
del Amo, A.6
Arrieta, I.7
Jurado, A.8
Palomino, P.9
Liu, F.T.10
Lahoz, C.11
|